From 2011, we expect to offer a proteomics service as a core facility. Charging models are still under discussion, and early informal contact is advised. We are not attracted to the model in which samples are received and analysed 'blind'. We firmly hold the view that this type of interaction is not particularly productive, especially in the early exploratory phase of a research programme - if we fail to run a sample of yours, at the same time as we obtain perfect results from our own controls, we would still have to charge you, and you would get nothing for your money. Often, some dialogue first can avoid such disappointments. See the "Contact" page under the tab "ABOUT US" for ways to get in touch.
Some recent case studies will serve to illustrate our involvement
Case Study 1
Colleagues wished to complete a quantitative proteomics study on cerebrospinal fluid samples. These samples were potentially infective, and we worked with them to perform appropriate bacteriological tests to prove that our protocols were effective at complete sterilisation of the samples.
Once this was established, the samples were received by us (from a Category 3 facility) and run on our instrumentation.
Colleagues wished to complete a quantitative proteomics study on cerebrospinal fluid samples. These samples were potentially infective, and we worked with them to perform appropriate bacteriological tests to prove that our protocols were effective at complete sterilisation of the samples.
Once this was established, the samples were received by us (from a Category 3 facility) and run on our instrumentation.
Case Study 3
A senior postdoc/research fellow wished to gain experience in proteomics, and has become embedded in the group according to our 'subscription; model. We give this individual sufficient training in principles and practice of quantitative mass spectrometry that they are able to run samples independently and analyse their own samples.
A senior postdoc/research fellow wished to gain experience in proteomics, and has become embedded in the group according to our 'subscription; model. We give this individual sufficient training in principles and practice of quantitative mass spectrometry that they are able to run samples independently and analyse their own samples.
Case Study 2
A group in Aarhus wished to develop a quantitative assay for a panel of acute phase proteins in domesticated animals. We helped them design a QconCAT, built the gene for them, expressed the protein in unlabelled an stable isotope labelled form, and helped them develop appropriate high sensitivity assays.
A group in Aarhus wished to develop a quantitative assay for a panel of acute phase proteins in domesticated animals. We helped them design a QconCAT, built the gene for them, expressed the protein in unlabelled an stable isotope labelled form, and helped them develop appropriate high sensitivity assays.